Evidence map›Paper›PMID 33329589›Full record

ArticleFrontiers in immunology2020

CD71

Shokrollah Elahi, Marco Antonio Vega-López, Vladimir Herman-Miguel, Carmen Ramírez-Estudillo, Javier Mancilla-Ramírez, Bruce Motyka, Lori West, Olaide Oyegbami

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. ST2Clinical and translational allergy · 2025
    Article
  7. Article
  8. Polyfunctional CD8Molecular oncology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Importance of CD71Journal of clinical laboratory analysis · 2024
    Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Immunoregulation role of the erythroid cells.Frontiers in immunology · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Shokrollah ElahiSchool of Dentistry, University of Alberta, Edmonton, AB, Canada.
Marco Antonio Vega-LópezDept. Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Mexico City, Mexico.
Vladimir Herman-MiguelDept. Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Mexico City, Mexico.
Carmen Ramírez-EstudilloDept. Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del IPN, Mexico City, Mexico.
Javier Mancilla-RamírezEscuela Superior deMedicina, Instituto Politecnico Nacional, Hospital de la Mujer, Secretaria de Salud, Mexico City, Mexico.
Bruce MotykaAlberta Transplant Institute and the Canadian Donation and Transplantation Research Program, Edmonton, AB, Canada.
Lori WestDepartment of Medical Microbiology and Immunology, University of Alberta, Edmonton AB, Canada.
Olaide OyegbamiSchool of Dentistry, University of Alberta, Edmonton, AB, Canada.
University of Alberta · CAInstituto Politécnico Nacional · MXCenter for Research and Advanced Studies of the National Polytechnic Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newborns are highly susceptible to infectious diseases. The underlying mechanism of neonatal infection susceptibility has generally been related to their under-developed immune system. Nevertheless, this notion has recently been challenged by the discovery of the physiological abundance of immunosuppressive erythroid precursors

Indexed as

Erythroid Precursor CellsImmunosuppression TherapyListeriosisAnimalsAnimals, NewbornAntigens, CDCOVID-19FemaleHeterograftsHumansInfant, NewbornListeria monocytogenesMaleMiceMice, Inbred BALB CReceptors, TransferrinAntigens, CDCD71 antigenReceptors, TransferrinCD71+ erythroid cellsCOVID-19immunosuppressionneonatal infectionsnewborns

Identifiers

PMID33329589
PMCPMC7732591
OpenAlexW3107187630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.